These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 10813530
41. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene. Sembeil R, Sanhadji K, Vivier G, Chargui J, Touraine JL. Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122 [Abstract] [Full Text] [Related]
42. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. El-Badri NS, Wang BY, Cherry, Good RA. Exp Hematol; 1998 Feb; 26(2):110-6. PubMed ID: 9472800 [Abstract] [Full Text] [Related]
43. Maintenance of functional human cancellous bone and human hematopoiesis in NOD/SCID mice. Hubin F, Humblet C, Belaid Z, Greimers R, Boniver J, Thiry A, Defresne MP. Cell Transplant; 2004 Feb; 13(7-8):823-31. PubMed ID: 15690985 [Abstract] [Full Text] [Related]
44. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hurwitz DR, Kirchgesser M, Merrill W, Galanopoulos T, McGrath CA, Emami S, Hansen M, Cherington V, Appel JM, Bizinkauskas CB, Brackmann HH, Levine PH, Greenberger JS. Hum Gene Ther; 1997 Jan 20; 8(2):137-56. PubMed ID: 9017418 [Abstract] [Full Text] [Related]
49. Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform. Benabdallah BF, Allard E, Yao S, Friedman G, Gregory PD, Eliopoulos N, Fradette J, Spees JL, Haddad E, Holmes MC, Beauséjour CM. Cytotherapy; 2010 May 20; 12(3):394-9. PubMed ID: 20331411 [Abstract] [Full Text] [Related]
50. Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells. Kerbauy DM, Lesnikov V, Torok-Storb B, Bryant E, Deeg HJ. Blood; 2004 Oct 01; 104(7):2202-3. PubMed ID: 15377576 [No Abstract] [Full Text] [Related]
51. Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Chen Y, Jacamo R, Shi YX, Wang RY, Battula VL, Konoplev S, Strunk D, Hofmann NA, Reinisch A, Konopleva M, Andreeff M. Blood; 2012 May 24; 119(21):4971-80. PubMed ID: 22490334 [Abstract] [Full Text] [Related]
52. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Schwarz EJ, Alexander GM, Prockop DJ, Azizi SA. Hum Gene Ther; 1999 Oct 10; 10(15):2539-49. PubMed ID: 10543618 [Abstract] [Full Text] [Related]
53. Transplantation of human hematopoietic progenitor cells transduced with a retroviral vector containing the human multidrug-resistance-1 gene for myeloprotective gene therapy. Laufs S, Baum C, Fruehauf S. Transplant Proc; 2002 Sep 10; 34(6):2325-9. PubMed ID: 12270418 [No Abstract] [Full Text] [Related]
54. Retroviral-mediated gene transfer into human bone marrow stromal cells: studies of efficiency and in vivo survival in SCID mice. Li KJ, Dilber MS, Abedi MR, Björkstrand B, Smith CI, Garoff H, Gahrton G, Xanthopoulos KG. Eur J Haematol; 1995 Nov 10; 55(5):302-6. PubMed ID: 7493676 [Abstract] [Full Text] [Related]
57. The potential use of bone marrow stromal cells for cochlear cell therapy. Sharif S, Nakagawa T, Ohno T, Matsumoto M, Kita T, Riazuddin S, Ito J. Neuroreport; 2007 Mar 05; 18(4):351-4. PubMed ID: 17435601 [Abstract] [Full Text] [Related]